New Jersey’s Hart and Celgene and Johnson & Johnson Executives Named to Scientific American Worldview 100 Most Influential People in Biotechnology

Trenton, NJ (June 18, 2015) – BioNJ President and CEO Debbie Hart, along with five other New Jersey executives, including Bob Hugin, Chairman and CEO, Celgene; Sol Barer, Ph.D., Founder, Celgene, and Managing Partner, SJ Barer Consulting; Robert Hariri, M.D., Ph.D., Chairman and Founder, Celgene Cellular Therapeutics; Paul Stoffels, M.D., CSO, Johnson & Johnson; and Shirley… Read the full article

New Jersey State Assemblywoman Lampitt Honored as BIO State Legislator of the Year

Philadelphia, PA. (June 17, 2015) – The Biotechnology Industry Organization (BIO) announced today its selection of New Jersey State Assemblywoman Pamela Lampitt (6th District) as a state Legislator of the Year for 2015. Assemblywoman Lampitt is the prime sponsor of A-2477, which authorizes the prescription and dispensing of biosimilar products in New Jersey. Assemblywoman Lampitt… Read the full article

BioNJ and Pennsylvania Bio Form International Partnership with Taiwan Bio Industry Organization

Agreement signed at the Biotechnology Industry Organization (BIO) International Convention TRENTON, NJ– BioNJ, New Jersey’s statewide trade association representing research-based life sciences companies and stakeholders, and Pennsylvania Bio, the statewide trade association representing Pennsylvania’s life sciences industry, announced today a memorandum of understanding (MOU) with Taiwan Bio Industry Organization, the largest biotechnology organization in Taiwan…. Read the full article

New Jersey Showcases Life Science Leaders and Innovations at World’s Largest Biotechnology Event

  TRENTON, NJ — New Jersey will showcase its business strengths in the life science industry to a global audience next week at the world’s largest biotechnology conference, BIO International, being held at the Philadelphia Convention Center on June 15-18. More than 15,000 attendees are expected to attend this year’s BIO International Convention, which regularly… Read the full article

Unanimous Approval of A2477 – Making Biological Drug Alternatives More Widely Available

TRENTON, NJ (May 14, 2015) — BioNJ, The Gateway to Health, is pleased with the passage of A2477, legislation that will allow greater Patient access to more affordable FDA-approved biologic medicines. Biological medicines are vital to the treatment of conditions such as cancer, diabetes, infectious diseases and a variety of immune disorders. BioNJ’s rallying cry… Read the full article

Assembly Committee Releases Bill A2477

Trenton, NJ – Proposed legislation that will allow greater patient access to more affordable FDA-approved biologic medicines was passed unanimously by the New Jersey Assembly Health and Human Services Committee today. The bill, A2477, also includes provisions for physician notification when a biosimilar bill is substituted for a biologic drug. “Biological medicines are vital to… Read the full article

BioNJ Appoints Three New Board Members

TRENTON, N.J.–(BUSINESS WIRE)–BioNJ, The Gateway to Health, announced the recent appointment of three new Board Members. The addition of these prominent industry leaders to the Board of Trustees reinforces BioNJ’s Mission to propel New Jersey’s dynamic life sciences ecosystem forward where Science is Supported, Companies are Created, Drugs are Developed and Patients are Paramount. The… Read the full article

BioNJ & NJDLWD Present New Jersey Life Sciences Week, April 20-24

TRENTON, N.J.–(BUSINESS WIRE)–BioNJ, The Gateway to Health, is pleased to announce that the week of April 20th through the 24th has been designated New Jersey Life Sciences Week. Each day features activities throughout the State which will showcase contributions that many of New Jersey’s life sciences community members are making to advance medical research, support… Read the full article